Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns.
Silver sulphadiazine has been applied to the burn wounds of 509 patients during the past 10 years. Eleven patients with burns covering more than 20 per cent of the body surface showed silver deposits in the mucosa of the lips, gingiva and cheeks. The colour of the burn wound was also slightly darker than in patients not treated with silver compounds. This darker colour spontaneously disappeared during the year following discharge from hospital. The pathogenesis of silver deposition has been discussed in relation to other published studies.
D000287:Administration, Topical; D000328:Adult; D002056:Burns / Q000188:drug therapy*; D005881:Gingiva / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000378:metabolism; D012837:Silver Sulfadiazine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use; D013411:Sulfadiazine / Q000378:metabolism*; D014018:Tissue Distribution; D014946:Wound Infection / Q000188:drug therapy / Q000517:prevention & control
D013411:Sulfadiazine; D012837:Silver Sulfadiazine